Cocrystal Pharma, Inc. (COCP) Financial Statements (2024 and earlier)

Company Profile

Business Address 19805 N. CREEK PARKWAY
BOTHELL, WA 98011
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments37,21958,70533,0107,4182,723748
Cash and cash equivalents37,21958,70533,0107,4182,723748
Restricted cash and investments7550505029 
Receivables716 556644 1
Prepaid expense      
Other undisclosed current assets2,1685683991691911,427
Total current assets:40,17859,32334,0158,2812,9432,176
Noncurrent Assets
Operating lease, right-of-use asset274478498677
Property, plant and equipment342453591431384119
Intangible assets, net (including goodwill)  19,09219,09219,09265,19565,195
Goodwill  19,09219,09219,09265,19565,195
Deposits noncurrent assets46464650  
Deferred costs      961
Other undisclosed noncurrent assets     4052,975
Total noncurrent assets:66220,06920,22720,25065,619119,250
TOTAL ASSETS:40,84079,39254,24228,53168,562121,426
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:9761,2971,0801,9991,077837
Employee-related liabilities1041268378 
Accounts payable6145786571,511616 
Accrued liabilities362615297405383 
Other undisclosed accounts payable and accrued liabilities      837
Debt 72739280214 
Deferred rent credit     3
Derivative instruments and hedges, liabilities  12617263569
Other undisclosed current liabilities233209178   
Total current liabilities:1,2161,5451,3582,2861,5571,406
Noncurrent Liabilities
Long-term debt and lease obligation  2983795371171,007
Long-term debt, excluding current maturities      1,007
Capital lease obligations117 
Finance lease, liability  73414
Liabilities, other than long-term debt 57    13,613
Deferred revenue and credits31
Deferred tax liabilities, net 13,582
Operating lease, liability 57291345523
Other undisclosed noncurrent liabilities  (291)(345)   
Total noncurrent liabilities: 5729837953711714,620
Total liabilities:1,2731,8431,7372,8231,67416,026
Equity
Equity, attributable to parent39,56777,54952,50525,70866,888105,400
Common stock89871363024
Additional paid in capital337,489336,544297,342260,932253,949243,419
Accumulated deficit(297,930)(259,093)(244,908)(235,260)(187,091)(138,043)
Total equity:39,56777,54952,50525,70866,888105,400
TOTAL LIABILITIES AND EQUITY:40,84079,39254,24228,53168,562121,426

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues   2,0146,564  
Gross profit:   2,0146,564  
Operating expenses(38,829)(14,221)(11,600)(54,970)(62,924)(8,262)
Other undisclosed operating income      7
Operating loss:(38,829)(14,221)(9,586)(48,406)(62,924)(8,262)
Nonoperating income (expense)(8)36(62)237294769
Loss, foreign currency transaction, before tax(18)(9)    
Interest and debt expense(2)(4)(8) (58) 
Other undisclosed income from continuing operations before equity method investments, income taxes   8 58 
Loss from continuing operations before income taxes:(38,839)(14,189)(9,648)(48,169)(62,630)(7,493)
Income tax benefit     13,5826,880
Loss from continuing operations:(38,839)(14,189)(9,648)(48,169)(49,048)(613)
Loss before gain (loss) on sale of properties:(14,189)(9,648)(48,169)(49,048)(613)
Net loss:(38,839)(14,189)(9,648)(48,169)(49,048)(613)
Other undisclosed net income (loss) attributable to parent24    
Net loss available to common stockholders, diluted:(38,837)(14,185)(9,648)(48,169)(49,048)(613)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(38,839)(14,189)(9,648)(48,169)(49,048)(613)
Comprehensive loss, net of tax, attributable to parent:(38,839)(14,189)(9,648)(48,169)(49,048)(613)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: